Northwestern Mutual Wealth Management
RANI icon

Northwestern Mutual Wealth Management’s Rani Therapeutics RANI Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio RANI Stock Details RANI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$836 Buy
+1,100
New +$975 ﹤0.01% 3819
2021
Q4 		– Sell
-1,000
Closed -$18K – 3291
2021
Q3 		$18K Buy
+1,000
New +$17.3K ﹤0.01% 2263

Other funds holding RANI

SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LP
Longaeva Partners Chicago, Illinois $4.58B AUM 43.91% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
HCM
Heights Capital Management San Francisco, California $433M AUM 8.59% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Northwestern Mutual Wealth Management's RANI Position: Q2 2026 in Review

Northwestern Mutual Wealth Management opened a new position in Rani Therapeutics (RANI) in Q2 2026: 1,100 shares worth $836. The stake represents ﹤0.01% of the portfolio and ranks #3819 among its holdings. This is a return to the name: Northwestern Mutual Wealth Management previously reported a position in RANI as recently as Q3 2021.

Northwestern Mutual Wealth Management first reported a position in RANI in Q3 2021 and has held it in 2 quarters since. The position peaked at $18K in Q3 2021. 68 funds tracked by Wall St. Rank hold RANI as of Q2 2026.

  • Northwestern Mutual Wealth Management held 1,100 shares of Rani Therapeutics worth $836 as of Q2 2026.
  • Rani Therapeutics was a new Northwestern Mutual Wealth Management position in Q2 2026.
  • Rani Therapeutics made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #3819 holding.
  • Northwestern Mutual Wealth Management first reported a position in Rani Therapeutics in Q3 2021 and has held it in 2 quarters since.
  • Northwestern Mutual Wealth Management's Rani Therapeutics position peaked at $18K in Q3 2021.
  • 68 funds tracked by Wall St. Rank held Rani Therapeutics as of Q2 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.